10 /100
LOW RISK
Score updated Jul 13, 2026

LEA — Lear Corporation Dilution Risk Tracker

Track LEA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LEA — Get alerts when the score changes →

As of July 13, 2026, Lear Corporation (LEA) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Lear Corporation has a market capitalization of $7.17B, 50.10M shares outstanding, 477 institutional holders tracked. Key dilution vectors include approximately 106 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
17
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LEA.
🔔 Track LEA — Get forecast alerts →

💹 Market Data

Market Cap$7.17B
Shares Outstanding50.10M
Float49.76M
Cash$885.50M
Debt$2.32B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.1% shares (2026Q1 vs prior)
477 institutional holders · 60.16M shares
#1 PZENA INVESTMENT MANAGEMENT LLC 6.76M shares
#2 BlackRock, Inc. 4.93M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 4.54M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.18M
Days to Cover2.9
% of Float4.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for LEA Shareholders

Lear Corporation (LEA) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for LEA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for LEA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for LEA alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track LEA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LEA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for LEA
📊 LEA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LEA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.